Showing 321 - 340 results of 383 for search '"human immunodeficiency virus"', query time: 0.08s Refine Results
  1. 321

    Cervical cancer screening utilization among HIV-positive women in Edo State, Nigeria by Ngozi R. Osunde, Mercy N. Anayo, Ona Patience, Favour E. Omoregie

    Published 2024-04-01
    “…Background: The enhanced risk of cervical cancer among women with human immunodeficiency virus (HIV) stems from the close association between HIV and increased rates of persistent human papillomavirus (HPV) infection. …”
    Get full text
    Article
  2. 322

    Transmission of HIV and HCV within Former Soviet Union Countries by Lazzat Aibekova, Aizada Bexeitova, Arailym Aldabergenova, Gonzalo Hortelano, Zhangwen Ge, Feng Yi, Yiming Shao, Jack DeHovitz, Sten H. Vermund, Syed Ali

    Published 2020-01-01
    “…To examine the transmission of blood-borne infections within this region, we analyzed the phylogenetic relationship of publically available sequences of two blood-borne viruses, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), from FSU countries. Methods. …”
    Get full text
    Article
  3. 323

    Risk factors for silicotuberculosis among miners: a scoping review by Mansour F. Saliba, Zeina Z. Karam, Moussa El Khayat, Elizabeth Koka, Dana A. Halwani, Joly Ghanawi, Layal Hneiny, Mey Jurdi, Hassan R. Dhaini, Umayya Musharrafieh, Rima R. Habib

    Published 2025-01-01
    “…Findings identified various STB risk factors including demographic factors such as age and sex, lifestyle factors including smoking and alcohol intake, clinical factors such as history of TB, grades of silicosis, and human immunodeficiency virus (HIV), in addition to occupational factors encompassing silica exposure, duration of employment, and type of work setting. …”
    Get full text
    Article
  4. 324

    Evaluating the Contribution of Nocardia spp. and Mycobacterium tuberculosis to Pulmonary Infections among HIV and Non-HIV Patients at the Komfo Anokye Teaching Hospital, Ghana by Samuel Asamoah Sakyi, Kwabena Owusu Danquah, Richard Dadzie Ephraim, Anthony Enimil, Venus Frimpong, Linda Ahenkorah Fondjo, Esther Love Darkoh

    Published 2018-01-01
    “…Tuberculosis (TB) is a major cause of human mortality particularly in association with the human immunodeficiency virus (HIV). Nocardia spp. has emerged as an opportunistic infection especially in HIV patients. …”
    Get full text
    Article
  5. 325

    COVID-19 in patients with severe mental illness: An analysis of in-patients at a psychiatric hospital in Cape Town by Haseena B. Sablay, Qhama Z. Cossie, Deirdre I. Pieterse

    Published 2025-01-01
    “…Reported comorbidities included nicotine use (71%, n = 181), hypertension (11%, n = 28) and human immunodeficiency virus (7%, n = 18). Most patients (62%, n = 156) were symptomatic for COVID-19. …”
    Get full text
    Article
  6. 326

    Factors affecting hematological abnormality in HIV-infected patients at Dr. Wahidin Sudirohusodo Hospital Makassar, Indonesia by I. Nyoman Yogi Wiraguna, Andi Fachruddin Benyamin, Risna Halim, Syakib Bakri, Sahyuddin Saleh, Hasyim Kasim, Andi Alfian Zainuddin

    Published 2024-09-01
    “…Introduction Human immunodeficiency virus (HIV) is characterized by a progressive damage of immune system, resulting in a number of opportunistic infections and hematological abnormalities, and become more severe in late stages. …”
    Get full text
    Article
  7. 327

    Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review by William R. Short, Parul Patel, Gustavo Verdier, Ana Puga, Vani Vannappagari, Annemiek de Ruiter, Bryn Jones

    Published 2024-12-01
    “…Abstract Lowering viral load during pregnancy is regarded as the most important method of reducing human immunodeficiency virus 1 (HIV-1) vertical transmission risk, and minimizing fetal exposure to drugs is a guiding principle during pregnancy. …”
    Get full text
    Article
  8. 328

    The impact of COVID-19 pandemic on HIV and AIDS care provision in South Africa: an integrative literature review by James R. Seretlo, Thifhelimbilu I. Ramavhoya, Fhumulani M. Mulaudzi, Rodwell Gundo, Tintswalo V. Nesengani, Mamoeng N. Kgatla, Mmapheko D. Peu

    Published 2024-10-01
    “…Worldwide, the coronavirus (COVID-19) pandemic has negatively impacted healthcare services, including human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) care. …”
    Get full text
    Article
  9. 329

    Incidence and predictors of mortality among HIV positive children on anti-retroviral therapy in the selected health facilities of West Wollega Zone, Western Ethiopia: Retrospective... by Gelane Gurmu, Emiru Merdassa, Gemechu Tiruneh, Keneni Efrem, Firezer Belay, Lalisa Mekonnen, Jira Wakoya Feyisa, Matiyos Lema, Adisu Tafari Shama, Markos Desalegn

    Published 2025-01-01
    “…<h4>Introduction</h4>The mortality rate among Human immunodeficiency Virus (HIV) who have started antiretroviral therapy (ART) continues to be increased in resource-limited countries, despite a decline in developed nations. …”
    Get full text
    Article
  10. 330

    Investigating the needs and barriers for prevention, control, and treatment of HIV/AIDS in transgender population: a systematic review of literature by Heshmatollah Sofimajidpour, Ghobad Moradi, Hojat Dehghanbanadaki, Marzieh Mahboobi, Mobin Azami, Parisa Khodakhah, Mohammad Aziz Rasouli, Yousef Moradi

    Published 2024-09-01
    “…Introduction The purpose of this systematic review was to identify the health needs related to prevention, control, and treatment of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) in transgender people from the perspective of transgender individuals and health policy-makers. …”
    Get full text
    Article
  11. 331

    Clinical profile and outcomes analysis of HIV infection by Ashwant Kumar, Yoganathan Chidambaram, Clement J. Dhas, Nekkanti Abilash, Murali Alagesan

    Published 2024-10-01
    “…Background India has the third largest number of human immunodeficiency virus (HIV) patients, but the national prevalence is continuously receding owing to dedicated health centers as well as highly active antiretroviral therapy (HAART), which is associated with newer manifestations and outcomes. …”
    Get full text
    Article
  12. 332

    Huge splenomegaly, a rare presentation of multicentric Castleman’s disease in an HIV-infected patient: a case report and literature review by Malihe Hasannezad, Abdolkarim Haji Ghadery, Sara Ghaderkhani, Armin Vazirian, Fereshteh Ameli, Farid Azmoudeh-Ardalan, Mohammad Reza Rafiian Naini, Ladan Abbasian

    Published 2024-10-01
    “…Nowa­days, multicentric CD is most commonly observed in individuals infected with human immunodeficiency virus (HIV) type 1, in association with Kaposi’s sarcoma. …”
    Get full text
    Article
  13. 333

    Symptomatic neurosyphilis in HIV-negative patients: a retrospective cohort study by Qiaoer Chen, Qiaoer Chen, Weiqi Wu, Lu Wang, Honghong Huang, Lingxing Wang

    Published 2025-02-01
    “…Few studies have focused on human immunodeficiency virus (HIV)-negative patients with symptomatic neurosyphilis, and the clinical outcomes and factors influencing the outcomes are unclear. …”
    Get full text
    Article
  14. 334
  15. 335

    NKG2C+CD57+ Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8+ T Cell Evolution towards Senescence by John Heath, Nicholas Newhook, Emilie Comeau, Maureen Gallant, Neva Fudge, Michael Grant

    Published 2016-01-01
    “…Expansion of NKG2C+CD57+ NK was measured in peripheral blood mononuclear cells (PBMC) from groups distinguished by HCMV and human immunodeficiency virus (HIV) infection status. Anti-HCMV antibody levels against HCMV-infected MRC-5 cell lysate were assessed by ELISA and HCMV-specific CD8+ T cell responses characterized by intracellular flow cytometry following PBMC stimulation with immunodominant HCMV peptides. …”
    Get full text
    Article
  16. 336
  17. 337

    Roles of mobile teams in tracing lost to follow–up clients: evidence from the optimization of COVID-19 vaccination uptake and routine immunization in Ekiti State by Saheed Dipo Isiaka, Dapo Awobeku, Akolade Uthman Jimoh, Mahfus Dauda, Olugbemisola Wuraola Samuel, Stephen Olabode Asaolu, Oluwafisayo Azeez Ayodeji, Sunday Atobatele, Segun Adenipekun, Chukwudinma Okoh, Zubair Adegoke, Sidney Sampson

    Published 2025-01-01
    “…Abstract Background Evidence from literature has established that tracing lost to follow-up clients is an effective strategy for complementing other mechanisms for infectious disease control like human immunodeficiency virus (HIV), tuberculosis, and other diseases such as Ebola. …”
    Get full text
    Article
  18. 338

    Antibiotic Resistance of Enteric Bacteria in HIV-Infected Patients at the Banka Ad-Lucem Hospital, West Region of Cameroon by Ornella J. T. Ngalani, Armelle T. Mbaveng, Wiliane J. T. Marbou, Roland Y. Ngai, Victor Kuete

    Published 2019-01-01
    “…Human immunodeficiency virus (HIV) infection is a serious problem throughout the world and especially in developing countries. …”
    Get full text
    Article
  19. 339

    Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors by Yen-Wen Chen, Helene Hardy, Christopher D. Pericone, Wing Chow

    Published 2020-07-01
    “…**Background:** Studies have shown an increase in weight among people living with human immunodeficiency virus (PLWH) who have also initiated integrase strand transfer inhibitors (INSTI). …”
    Get full text
    Article
  20. 340

    Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice by Qi Ma, Jing Yang, Xiaoguang Zhang, Hongxia Li, Yanzhe Hao, Xia Feng

    Published 2025-01-01
    “…Background: The development of a protective vaccine is critical for conclusively ending the human immunodeficiency virus (HIV) epidemic. Methods: We constructed nucleotide-modified mRNA vaccines expressing HIV-1 Env and Gag proteins. …”
    Get full text
    Article